The Wallace H. Coulter Foundation Optimizes Academia Process
“We have very clear timelines, milestones, and we define the critical experiment that, if it’s successful will bring value to the technology and make it ready for follow-up funding.”
Blog
Vasomedical Proves Itself A Company To Watch On The Fast Track to Growth
With the recent acquisition of the two Chinese companies, restructuring, and the addition of a new CFO, Vasomedical is now positioned to move forward and further implement plans for expansion and growth.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
NeoStem Expected To Have Short and Long Term Value Drivers
NeoStem has transformed itself over the last year and half with two acquisitions, multiple financings and their expansion into China.
Citigroup Pricing The Offering of GSVC [NASDAQ:GSVC] Later This Week
Citigroup [NYSE:CITI] pricing GSVC’s $100 million raise this week. As of end of trading Sept 19th, GSVC stock is trading at about $14.37 and seems undervalued for several reasons.
ImmunoGenetix Discovers a Safer Approach To HIV Treatment
James Laufenberg, CEO of ImmunoGenetix was interviewed by OneMedRadio where he discussed a therapeutic DNA based composition to treat HIV, GenePro.
This Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business in his new column “This Week In Diagnostics“. Peter has over 30 years experience as a scientist, science journalist, and publisher.
Advaxis CEO Tom Moore Discovers A New Way To Fight Cancer
OneMedRadio interviewed Tom Moore, CEO and Chairman of the Board of Directors of Advaxis [OTC:ADXS]. He discusses the company’s novel immunotherapy technology.
The Week In Diagnostics
Peter Winter, consultant to the biotechnology industry brings us financings and business developments in the global diagnostics business. Peter has over 30 years experience as a scientist, science journalist, and publisher.
AdvaMed 2011 Featuring Over 70 Company Presentations
The conference will feature over 70 company presentations. Below are some interesting technologies attendees can expect to hear from.